Head-to-head · WeighScore
Strut Health vs Velvet Rx
By GLP-1 ScorecardUpdated
Score comparison
Strut Health has the higher recorded score — 79.4/100 to 58.1/100.
Strut Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Before you choose
Before comparing the headline prices, the Strut Health review and the Velvet Rx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Strut Health vs Virta Health and TeleCareSpot vs Velvet Rx compare each of them with another graded program, and the list of alternatives to Strut Health ranks the programs closest to Strut Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Strut Health | Velvet Rx |
|---|---|---|
| WeighScore | 79.4/100 | 58.1/100 |
| Grade | C+ | C |
| Site position | #26 | #413 |
| Semaglutide | Oral from $99/30 days; injection from $129/mo; oral page conflicts at $199—confirm dose and renewal | $99 advertised starting offer (renewal unverified) |
| Tirzepatide | Oral $199/30 days; injection from $149/mo depending on prescribed dose—confirm quantity and renewal | $179 advertised starting offer (renewal unverified) |
| Coverage | FAQ says all states except Arkansas as of September 2024; confirm current medication and route eligibility | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strengths
- Dedicated pages list separate oral and injectable semaglutide and tirzepatide prices
- Provider consultations, follow-ups and shipping are advertised as included
- Current help describes an account cancellation button; terms also provide an email route
- Tirzepatide pages advertise flat pricing across strengths, subject to confirmation for the selected prescription
What to consider
- Dedicated oral semaglutide page lists $99 while the general semaglutide page lists oral $199; help warns dose increases raise price
- Product pages describe buccal semaglutide while dose help describes sublingual use; exact formula and instructions need confirmation
- 48-hour cancellation descriptions differ between shipment and processing; processed prescriptions are not refundable
- Assigned GLP-1 pharmacy and a required or included lab program were not established; the general state footprint is dated September 2024
Site position #413 · C
Strengths
- Advertises $99 semaglutide, $179 tirzepatide and $149 oral GLP-1 offers
- Terms identify Rocket Health Inc and provide an Oceanside, California address
- Names RedRock, Health Warehouse, Precision Compounding Pharmacy and Triad Rx in its pharmacy network
- Lists injectable and oral treatment options
What to consider
- Introductory amounts do not establish the ongoing charge or billing interval
- The selected formulation and product-to-pharmacy assignment remain unconfirmed
- State-specific product availability must be confirmed; a licensing statement is not a nationwide shipping guarantee
- Processed or discounted orders may be nonrefundable under the published terms
Featured provider
Strut Health
Factor scores not reassessed.Strut Health scores 79.4/100 (C+). Four compounded offers with separate oral and injectable prices; semaglutide's conflicting oral prices and dose-related costs need a selected prescription quote.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.